Emami share buyback: Board to consider repurchase proposal on September 17; stock surges 5%

Shares of Emami Ltd rallied in the early trade on Tuesday, September 15, after the company said its board will meet on September 17 to consider a proposal for the buyback of its fully paid-up equity shares.

The board will also consider matters related or incidental to the proposed share repurchase in accordance with applicable provisions of the Companies Act and SEBI’s buyback regulations.

The company will disclose the outcome of the meeting to the stock exchanges after the board meeting.

The stock jumped as much as 5.18% to ₹382.65 on the NSE.

About Emami

Emami is a Kolkata-based FMCG company focused on personal care and healthcare products, with a portfolio that includes brands such as BoroPlus, Navratna, Zandu, Kesh King, Dermicool and Mentho Plus.

The company reported a turnover of ₹3,780 crore in FY26 and has more than 25 brands, with 10 brands generating annual revenue of over ₹100 crore.

It has a distribution network covering around 5.4 million outlets in India and a presence across more than 70 countries.

Emami targets 25% turnover from strategic investments by FY30

In August 2026, FMCG major Emami Ltd said it expects consolidated revenue from its strategic investments portfolio to nearly quadruple to around 25% of consolidated turnover by FY'30 from about 6% in FY26, riding on a revival in rural demand and continued urban premiumisation, a top official said on Tuesday.

The strategic investments portfolio comprises stakes in newer, mostly founder-led consumer brands acquired over the past few years.

Addressing shareholders at Emami's 43rd AGM, the company's Non-Executive Chairman R S Goenka said the strategic investments portfolio, built through stakes in brands such as The Man Company, Brillare, Axiom Ayurveda and IncNut Digital, is projected to contribute around 16% of turnover in the current fiscal year itself, up from 6% in FY26.

"As rural purchasing power recovers and GST rationalisation widens access to organised categories, we believe Emami is structurally positioned to capture a disproportionate share of that recovery," Goenka said, adding that a favourable monsoon and improving agricultural output were reviving a rural market that had lagged urban consumption for several years.

Goenka said the urban premiumisation curve continued to work in the company's favour, with rising aspirations, a growing focus on wellness, rapid digital adoption and increasing demand for trusted brands opening up further opportunities.

Latest update

Last week, the company said it has extended its skincare brand BoroPlus into the baby-care segment, with the launch of a new range of products.

Emami announced the launch of 'BoroPlus FromMaa', a new range of baby-care products.

The products are paediatrician-approved and dermatologist-tested, the company said in a statement.

The portfolio includes baby lotion, soap, shampoo, massage oil, powder and diaper rash cream.

Emami Q1 FY27 earnings

The FMCG major reported a nearly 15% year-on-year (YoY) decline in consolidated net profit to ₹138.94 crore for the first quarter ended June 30, 2026 (Q1 FY27), weighed down by a sharp rise in expenses amid elevated crude prices, inflationary pressures and disruptions caused by the West Asia conflict.

The company had posted a consolidated net profit of ₹164.26 crore in the year-ago quarter, according to a regulatory filing.

Consolidated revenue from operations rose about 15% to ₹1,039.21 crore during the quarter under review, compared with ₹904.09 crore logged in the corresponding quarter of the previous fiscal.

However, on a standalone basis, the net profit for the quarter rose nearly 12% to ₹182.22 crore from $163.09 crore.

The company said that domestic business grew 20% during the quarter, while on a like-to-like basis, growth stood at 12% with volume growth of 8% after adjusting for the previous year's Axiom Ayurveda and IncNut Digital numbers.

Emami share price trend

Shares of Emami have delivered negative returns across most key time frames. The stock has declined around 1% over the past five trading sessions, around 10% in the past month and more than 14% over the past six months. On a year-to-date (YTD) basis, Emami shares are down more than 30.6%, while the stock has fallen over 39% in the past 12 months.